Literature DB >> 3670618

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.

P A van Doorn1, A Brand, M Vermeulen.   

Abstract

With the use of a mixed hemagglutination test (MHT), circulating antibodies against human peripheral nerve tissue (PNT) were found in 22 of 38 patients with Guillain-Barré syndrome (GBS) or chronic relapsing demyelinating inflammatory polyneuropathy (CR-DIP). The antibodies were found in only 1 of 34 patients with polyneuropathy of other origin, and in 3 of 32 patients without polyneuropathy. The presence of antibodies was related to response to intravenous gamma globulin treatment in CR-DIP patients. Antibodies against PNT may be pathogenic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670618     DOI: 10.1212/wnl.37.11.1798

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  G Comi; L Roveri
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Avinash Chandra Singh
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

3.  Experimental allergic neuritis: effect of plasma infusions.

Authors:  G K Harvey; J D Pollard; K Schindhelm; J G McLeod
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  A 3-month-old baby with H1N1 and Guillain-Barré syndrome.

Authors:  Alexandra Vasconcelos; Francisco Abecasis; Rita Monteiro; Cristina Camilo; Marisa Vieira; Mamede de Carvalho; Manuela Correia
Journal:  BMJ Case Rep       Date:  2012-03-27

Review 5.  Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Richard A C Hughes; Jane Pritchard
Journal:  Cochrane Database Syst Rev       Date:  2015-08-25

Review 6.  Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.

Authors:  Melvin Berger; Daniel E McCallus; Cindy Shin-Yi Lin
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.